Consolidated Statements of Cash Flows (unaudited) - USD ($) $ in Thousands	3 Months Ended
	May. 30, 2015	May. 31, 2014
Operating Activities
Net earnings	$ 12,126	$ 6,102
Adjustments to reconcile net earnings to net cash provided by (used in) operating activities:
Depreciation and amortization	7,741	6,766
Stock-based compensation	1,040	1,250
Deferred income taxes	358	(501)
Excess tax benefits from stock-based compensation	(3,619)	(1,589)
Gain on disposal of assets	(102)	(453)
Other, net	39	12
Changes in operating assets and liabilities:
Receivables	10,820	586
Inventories	(1,240)	(2,268)
Accounts payable and accrued expenses	(18,129)	(11,677)
Billings in excess of costs and earnings on uncompleted contracts	7,191	985
Refundable and accrued income taxes	5,361	2,825
Other, net	(731)	(842)
Net cash provided by (used in) operating activities	20,855	1,196
Investing Activities
Capital expenditures	(8,753)	(8,738)
Proceeds from sales of property, plant and equipment	1	201
Sales/maturities of restricted investments	0	798
Purchases of marketable securities	(35,787)	(484)
Sales/maturities of marketable securities	1,696	868
Investments in corporate-owned life insurance policies	(823)	0
Net cash provided by (used in) investing activities	(43,666)	(7,355)
Financing Activities
Proceeds from issuance of debt	1,199	0
Payments on debt	(10)	(12)
Shares withheld for taxes, net of stock issued to employees	(2,028)	(3,164)
Excess tax benefits from stock-based compensation	3,619	1,589
Repurchase and retirement of common stock	0	(863)
Dividends paid	(3,215)	(3,078)
Net cash provided by (used in) financing activities	(435)	(5,528)
Decrease in cash and cash equivalents	(23,246)	(11,687)
Effect of exchange rates on cash	(735)	315
Cash and cash equivalents at beginning of year	52,185	28,465
Cash and cash equivalents at end of period	28,204	17,093
Noncash Activity
Capital expenditures in accounts payable	$ 1,363	$ 921